Increased Circulating Cathepsin K in Patients with Chronic Heart Failure
about
Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease.Engineered nanomaterial-induced lysosomal membrane permeabilization and anti-cathepsin agents.Cathepsin K knockout protects against cardiac dysfunction in diabetic mice.Cathepsin K activity controls cardiotoxin-induced skeletal muscle repair in mice.Clinical significance of cathepsin L and cathepsin B in dilated cardiomyopathy.Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity.
P2860
Increased Circulating Cathepsin K in Patients with Chronic Heart Failure
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Increased Circulating Cathepsin K in Patients with Chronic Heart Failure
@ast
Increased Circulating Cathepsin K in Patients with Chronic Heart Failure
@en
type
label
Increased Circulating Cathepsin K in Patients with Chronic Heart Failure
@ast
Increased Circulating Cathepsin K in Patients with Chronic Heart Failure
@en
prefLabel
Increased Circulating Cathepsin K in Patients with Chronic Heart Failure
@ast
Increased Circulating Cathepsin K in Patients with Chronic Heart Failure
@en
P2093
P2860
P1433
P1476
Increased Circulating Cathepsin K in Patients with Chronic Heart Failure
@en
P2093
Chengzhi Jin
Dazhi Ding
Dongmei Zhou
Ennan Fang
Guang Yang
Guanghao Piao
Guangxian Zhao
Haiying Jiang
Jiyong Jin
P2860
P304
P356
10.1371/JOURNAL.PONE.0136093
P407
P577
2015-08-24T00:00:00Z